24 days since our last press release. In a trial designed to be a month long I would say a great deal of data has become available and since we have been at it since mid December I would think that Brilacidin’s performance has become clear. I know I am biased and a cheerleader but I also know that whatever is released to us will be based on a solid data set that Leo can do use for strategic planning and the FDA or our suitors can use to advance their agenda. Basically, not too much in terms of guesswork to go forward in whatever direction we go. I’m betting we have a winner and the fore play is over.